Galapagos « Terug naar discussie overzicht

Overname van....Gilead....?

3 Posts

Omlaag ↓

diederique 22 september 2016 21:19

kan zomaar gebeuren...

.....The latest idea? That the Dublin drugmaker may target Gilead, whose $107 billion market cap is quite a ways off
of the heights it reached last year.

www.fiercepharma.com/pharma/allergan-...

diederique 23 september 2016 00:25

Will Gilead Make a Good Fit for Allergan?

Allergen’s surprise interest emerged without any earlier indications of interest in companies focused on NASH or liver diseases. Given the backdrop of recent acquisitions, the market is abuzz with rumors about Gilead being the next potential target for Allergan.

www.investopedia.com/news/will-gilead...

diederique 23 september 2016 21:54

Allergan joins a growing field of companies intent on conquering NASH, which include Gilead Sciences Inc. GILD, -0.10% , Bristol-Myers Squibb Co. BMY, +0.23% , Intercept Pharmaceuticals Inc. ICPT, -2.42% , Galmed Pharmaecuticals Ltd. GLMD, -1.64% , Astra-Zeneca Plc AZN, -0.88% and Novartis AG NVS, -0.53% , among others, according to BioMedTracker.

www.marketwatch.com/story/allergan-is...

3 Posts

Aantal posts per pagina: 20 50 100 | Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met uw e-mailadres en wachtwoord.

Direct naar Forum

Detail

Vertraagd	12 mrt 2025 12:55
Koers	24,340
Verschil	+0,800 (+3,40%)
Hoog	24,460
Laag	23,700
Volume	20.344
Volume gemiddeld	121.010
Volume gisteren	108.480

Galapagos nieuws meer

19 feb	Deutsche Bank verlaagt koersdoel Gala...
18 feb	Tang Capital meldt flink belang in Ga...	1
13 feb	KBC Securities verlaagt koersdoel Gal...
13 feb	AEX houdt dapper stand op Super Thurs...	3
12 feb	Cashburn en kaspositie Galapagos vrij...
12 feb	Beursblik: focus op opsplitsingplan b...
10 feb	Deze bedrijven kunnen deze week voor ...
23 jan	Barclays zet Galapagos op de verkoopl...
19 jan	IMCD uitblinker op goedgeluimd Damrak
09 jan	Van Lanschot: belangrijkste wending o...